Studies on human urinary trypsin inhibitor. 1. Its modification on treatment of urine with acid

Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.

Thrombosis and haemostasis·1998

Effects of electric footshock and water immersion restraint stresses on fibrinolytic parameters in the plasma of rats.

Thrombosis research·1998

Proteolysis of highly polysialylated NCAM by the tissue plasminogen activator-plasmin system in rats.

Neuroscience letters·1998

Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery.

Atherosclerosis·1998

Severe heat stroke associated with high plasma levels of plasminogen activator inhibitor 1.

Burns : journal of the International Society for Burn Injuries·1998

Solitary fibrous tumor of the pleura causing recurrent hypoglycemia by secretion of insulin-like growth factor II.

Pathology international·1998

Complement activation characterizes a high mortality subgroup in pulmonary embolism: An observational proteomic study.

Thrombosis research·2026

The calf clot of the lungs: Detection, overdiagnosis, and structured surveillance in isolated subsegmental pulmonary embolism.

Thrombosis research·2026

Perioperative haemostatic management and bleeding outcomes in congenital factor VII deficiency: a retrospective cohort study.

Thrombosis research·2026

Fibrinogen activity and postpartum hemorrhage risk in women with congenital fibrinogen disorders: A multicenter real-world study.

Thrombosis research·2026

The Factor VII mutation F7 c.760T>C (FVIIp.Cys254Arg) is causative for Factor VII deficiency by impairing secretion.

Thrombosis research·2026

A human-cell recombinant prethrombin-2 platform producing thrombin with enhanced fibrinogen processing for in vitro applications.

Thrombosis research·2026

Efficacy and safety of ripertamab in immune-mediated glomerular diseases with proteinuria: an expanded real-world cohort study.

Frontiers in immunology·2026

IL-23 and monocyte interactions redirect human Th17.1 cells to an IL-17AhighIFN-γhigh potentially pathogenic profile.

Frontiers in immunology·2026

Monoclonal antibodies associated IgA nephropathy or other nephropathies.

Frontiers in pharmacology·2026

Comparative safety outcomes of three venous access routes for totally implantable venous access port placement and exploratory assessment of pre-removal catheter-related thrombosis in breast cancer patients.

Frontiers in oncology·2026

Response to Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Haematologica·2026

[Analysis of efficacy and prognosis of allogeneic hematopoietic stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2026

Related Experiment Videos

Studies on human urinary trypsin inhibitor. 1. Its modification on treatment of urine with acid

Related Concept Videos

Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.

Effects of electric footshock and water immersion restraint stresses on fibrinolytic parameters in the plasma of rats.

Proteolysis of highly polysialylated NCAM by the tissue plasminogen activator-plasmin system in rats.

Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery.

Severe heat stroke associated with high plasma levels of plasminogen activator inhibitor 1.

Solitary fibrous tumor of the pleura causing recurrent hypoglycemia by secretion of insulin-like growth factor II.

Complement activation characterizes a high mortality subgroup in pulmonary embolism: An observational proteomic study.

The calf clot of the lungs: Detection, overdiagnosis, and structured surveillance in isolated subsegmental pulmonary embolism.

Perioperative haemostatic management and bleeding outcomes in congenital factor VII deficiency: a retrospective cohort study.

Fibrinogen activity and postpartum hemorrhage risk in women with congenital fibrinogen disorders: A multicenter real-world study.

The Factor VII mutation F7 c.760T>C (FVIIp.Cys254Arg) is causative for Factor VII deficiency by impairing secretion.

A human-cell recombinant prethrombin-2 platform producing thrombin with enhanced fibrinogen processing for in vitro applications.

Efficacy and safety of ripertamab in immune-mediated glomerular diseases with proteinuria: an expanded real-world cohort study.

IL-23 and monocyte interactions redirect human Th17.1 cells to an IL-17AhighIFN-γhigh potentially pathogenic profile.

Monoclonal antibodies associated IgA nephropathy or other nephropathies.

Comparative safety outcomes of three venous access routes for totally implantable venous access port placement and exploratory assessment of pre-removal catheter-related thrombosis in breast cancer patients.

Response to Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

[Analysis of efficacy and prognosis of allogeneic hematopoietic stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome].

Related Experiment Videos

Studies on human urinary trypsin inhibitor. 1. Its modification on treatment of urine with acid

Related Concept Videos

Related Articles